Year: 2025
Type: letter
Source: Arthritis & Rheumatology
DOI: 10.1002/art.43123
Institutions: Oklahoma Medical Research Foundation, AbbVie (United States)
Language: English
Open Access status: bronze
Funder: AbbVie Biotherapeutics
OpenAlex ID: W4406847847